Skip to main content
Top
Published in: Archives of Virology 3/2008

01-03-2008 | Original Article

Molecular epidemiology of wild poliovirus type 1 circulation in West and Central Africa, from 1997 to 1999, using genotyping with a restriction fragment length polymorphism assay

Authors: Ionela Gouandjika-Vasilache, Cara C. Burns, Nicksy Gumede, Sophie Guillot, Didier Ménard, Annick Dosseh, Chantal Akoua-Koffi, Mark A. Pallansch, Olen M. Kew, Francis Delpeyroux

Published in: Archives of Virology | Issue 3/2008

Login to get access

Abstract

Virological surveillance is an important element in the Polio Eradication Initiative to provide information rapidly about circulating wild polioviruses. Molecular tools have been developed to identify the serotype of the poliovirus strains and whether they are of vaccine or wild origin (intratypic differentiation) and to perform the molecular epidemiology of wild strains. The main objective of this study was to show that restriction fragment length polymorphism (RFLP) is a tool that can be used for molecular epidemiology of wild polioviruses. This is retrospective study of poliovirus type 1 strains received at the Institut Pasteur of Bangui (IPB), a WHO Regional Reference Laboratory for Africa, since 1994. We describe our experience with isolates from Western and Central Africa and show a positive correlation between the genotypes as determined by sequencing the gene for the VP1 capsid protein and the RFLP patterns. Although genomic sequencing is the gold standard method for detailed molecular epidemiology analysis of poliovirus isolates, these results show that RFLP is a potentially valuable tool for molecular epidemiological analysis of poliovirus type 1 strains: it could be used by many laboratories as a rapid method for ITD and genotype screening where sequencing capacity is not readily available.
Literature
1.
go back to reference Anonymous (2006) Imported vaccine-associated paralytic poliomyelitis-Unated States, 2005. MMWR Morb Mortal Wkly Rep 55:97–99 Anonymous (2006) Imported vaccine-associated paralytic poliomyelitis-Unated States, 2005. MMWR Morb Mortal Wkly Rep 55:97–99
2.
go back to reference Anonymous (2006) Resurgence of Wild Poliovirus Type 1 Transmission and Consequences of Importation-21 Countries, 2002–2005. MMWR Morb Mortal Wkly Rep 55:145–150 Anonymous (2006) Resurgence of Wild Poliovirus Type 1 Transmission and Consequences of Importation-21 Countries, 2002–2005. MMWR Morb Mortal Wkly Rep 55:145–150
3.
go back to reference Balanant J, Guillot S, Candrea A, Delpeyroux F, Crainic R (1991) The natural genomic variability of poliovirus analyzed by a restriction frangment length polymorphism assay. Virology 184:645–654PubMedCrossRef Balanant J, Guillot S, Candrea A, Delpeyroux F, Crainic R (1991) The natural genomic variability of poliovirus analyzed by a restriction frangment length polymorphism assay. Virology 184:645–654PubMedCrossRef
4.
go back to reference Gouandjika I, Legall P, Kelembo EK, Mathiot CC, Morvan JM (1995) Change in the type of wild poliovirus circulating in the Central African Republic between 1991 and 1994. Trans R Soc Trop Med Hyg 89:576PubMedCrossRef Gouandjika I, Legall P, Kelembo EK, Mathiot CC, Morvan JM (1995) Change in the type of wild poliovirus circulating in the Central African Republic between 1991 and 1994. Trans R Soc Trop Med Hyg 89:576PubMedCrossRef
5.
go back to reference Kew O, Morris-Glasgow V, Landaverde M, Burns C, Shaw J, Garib Z, Andre J, Blackman E, Freeman CJ, Jorba J, Sutter R, Tambini G, Venczel L, Pedreira C, Laender F, Shimizu H, Yoneyama T, Miyamura T, van Der Avoort H, Oberste MS, Kilpatrick D, Cochi S, Pallansch M, de Quadros C (2002) Outbreak of poliomyelitis in Hispaniola associated with circulating type 1 vaccine-derived poliovirus. Science 296:356–359PubMedCrossRef Kew O, Morris-Glasgow V, Landaverde M, Burns C, Shaw J, Garib Z, Andre J, Blackman E, Freeman CJ, Jorba J, Sutter R, Tambini G, Venczel L, Pedreira C, Laender F, Shimizu H, Yoneyama T, Miyamura T, van Der Avoort H, Oberste MS, Kilpatrick D, Cochi S, Pallansch M, de Quadros C (2002) Outbreak of poliomyelitis in Hispaniola associated with circulating type 1 vaccine-derived poliovirus. Science 296:356–359PubMedCrossRef
6.
go back to reference Kew OM, Mulders MN, Lipskaya GY, da Silva EE, Pallansch MA (1995) Molecular epidemiology of polioviruses. In: Kew ON (ed) Molecular Epidemiology. Seminars in Virology. Academic, New York, pp 401–414 Kew OM, Mulders MN, Lipskaya GY, da Silva EE, Pallansch MA (1995) Molecular epidemiology of polioviruses. In: Kew ON (ed) Molecular Epidemiology. Seminars in Virology. Academic, New York, pp 401–414
7.
go back to reference Kew OM, Yang CF, Nottay B, Pallansch MA (1993) The role of virologic surveillance in the global initiative to eradicate poliomyelitis. In: Kurstak E (ed) Control of virus diseases, 2nd edn., Marcel Dekker, New York, pp 215–245 Kew OM, Yang CF, Nottay B, Pallansch MA (1993) The role of virologic surveillance in the global initiative to eradicate poliomyelitis. In: Kurstak E (ed) Control of virus diseases, 2nd edn., Marcel Dekker, New York, pp 215–245
8.
go back to reference Kimura M (1980) A simple method for estimating evolutionary rates of base substitutions through comparative studies of nucleotide sequences. J Mol Evol 16:111–120PubMedCrossRef Kimura M (1980) A simple method for estimating evolutionary rates of base substitutions through comparative studies of nucleotide sequences. J Mol Evol 16:111–120PubMedCrossRef
9.
go back to reference Liu HM, Zheng DP, Zhang LB, Oberste MS, Pallansch MA, Kew OM (2000) Molecular evolution of a type 1 wild-vaccine poliovirus recombinant during widespread circulation in China. J Virol 74:11153–11161PubMedCrossRef Liu HM, Zheng DP, Zhang LB, Oberste MS, Pallansch MA, Kew OM (2000) Molecular evolution of a type 1 wild-vaccine poliovirus recombinant during widespread circulation in China. J Virol 74:11153–11161PubMedCrossRef
10.
go back to reference Morvan JM, Chezzi C, Gouandjika I, Reimerink JH, van der Avoort HG (1997) The molecular epidemiology of type 1 poliovirus in Central African Republic. J Gen Virol 78(Pt 3):591–599PubMed Morvan JM, Chezzi C, Gouandjika I, Reimerink JH, van der Avoort HG (1997) The molecular epidemiology of type 1 poliovirus in Central African Republic. J Gen Virol 78(Pt 3):591–599PubMed
11.
go back to reference Moss EG, O’Neill R, Racaniello VRM. o. a. s. o. a. a. p. t. s. J. V. (1989) Mapping of atttenuating sequences of an avirulent poliovirus type 2 strain. J Virol 63:1884–1890 Moss EG, O’Neill R, Racaniello VRM. o. a. s. o. a. a. p. t. s. J. V. (1989) Mapping of atttenuating sequences of an avirulent poliovirus type 2 strain. J Virol 63:1884–1890
12.
go back to reference Rico-Hesse R, Pallansch MA, Nottay BK, Kew OM (1987) Geographic distribution of wild poliovirus type 1 genotypes. Virology 160:311–322PubMedCrossRef Rico-Hesse R, Pallansch MA, Nottay BK, Kew OM (1987) Geographic distribution of wild poliovirus type 1 genotypes. Virology 160:311–322PubMedCrossRef
13.
go back to reference Saitou N, Nei M (1987) The neighbor-joining method: a new method for reconstructing phylogenetic trees. Mol Biol Evol 4:406–425PubMed Saitou N, Nei M (1987) The neighbor-joining method: a new method for reconstructing phylogenetic trees. Mol Biol Evol 4:406–425PubMed
14.
go back to reference van der Avoort HG, Hull BP, Hovi T, Pallansch MA, Kew OM, Crainic R, Wood DJ, Mulders MN, van Loon AM (1995) Comparative study of five methods for intratypic differentiation of polioviruses. J Clin Microbiol 33:2562–2566PubMed van der Avoort HG, Hull BP, Hovi T, Pallansch MA, Kew OM, Crainic R, Wood DJ, Mulders MN, van Loon AM (1995) Comparative study of five methods for intratypic differentiation of polioviruses. J Clin Microbiol 33:2562–2566PubMed
15.
go back to reference Ward NA, Kim-Farley RJ, Milstein JB, Hull HF, Torel C, de Quadros C (1993) Poliomyelitis eradication. Expanded programme on immunization of the World Health Organization. In: Kurstak E (ed) Control of virus diseases, 2nd edn. Marcel Dekker, New York, pp 247–266 Ward NA, Kim-Farley RJ, Milstein JB, Hull HF, Torel C, de Quadros C (1993) Poliomyelitis eradication. Expanded programme on immunization of the World Health Organization. In: Kurstak E (ed) Control of virus diseases, 2nd edn. Marcel Dekker, New York, pp 247–266
16.
go back to reference WHO (1997) Manual for the virological investigation of polio. In WHO/EPI/GEN/97.01. World Health Organization WHO (1997) Manual for the virological investigation of polio. In WHO/EPI/GEN/97.01. World Health Organization
17.
go back to reference WHO (2000) Global polio eradication initiative. Strategic plan 2001–2005. WHO/POLIO/00.05. World Health Organization, Geneva WHO (2000) Global polio eradication initiative. Strategic plan 2001–2005. WHO/POLIO/00.05. World Health Organization, Geneva
18.
go back to reference WorldHealthAssembly (1988) Global eradication of poliomyelitis by the year 2000: resolution of the 41st World Health Assembly. World Health Organization (WHA resolution no. 41.28), Geneva, Switzerland WorldHealthAssembly (1988) Global eradication of poliomyelitis by the year 2000: resolution of the 41st World Health Assembly. World Health Organization (WHA resolution no. 41.28), Geneva, Switzerland
19.
go back to reference Wright PF, Kim-Farley RJ, de Quadros CA, Robertson SE, Scott RM, Ward NA, Henderson RH (1991) Strategies for the global eradication of poliomyelitis by the year 2000. N Engl J Med 325:1774–1779PubMedCrossRef Wright PF, Kim-Farley RJ, de Quadros CA, Robertson SE, Scott RM, Ward NA, Henderson RH (1991) Strategies for the global eradication of poliomyelitis by the year 2000. N Engl J Med 325:1774–1779PubMedCrossRef
Metadata
Title
Molecular epidemiology of wild poliovirus type 1 circulation in West and Central Africa, from 1997 to 1999, using genotyping with a restriction fragment length polymorphism assay
Authors
Ionela Gouandjika-Vasilache
Cara C. Burns
Nicksy Gumede
Sophie Guillot
Didier Ménard
Annick Dosseh
Chantal Akoua-Koffi
Mark A. Pallansch
Olen M. Kew
Francis Delpeyroux
Publication date
01-03-2008
Publisher
Springer Vienna
Published in
Archives of Virology / Issue 3/2008
Print ISSN: 0304-8608
Electronic ISSN: 1432-8798
DOI
https://doi.org/10.1007/s00705-007-0001-x

Other articles of this Issue 3/2008

Archives of Virology 3/2008 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine